Eyepoint Pharmaceuticals Inc (EYPT) — Working Capital to Net Assets Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Working Capital to Net Assets ratio of 92.9% as of September 2025. Working capital of $186.01 Million (current assets of $216.11 Million minus current liabilities of $30.09 Million) is measured against net assets of $200.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See EYPT net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Eyepoint Pharmaceuticals Inc Working Capital to Net Assets (2000–2024)
This chart shows how Eyepoint Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 92.9%, reflecting working capital of $186.01 Million against net assets of $200.18 Million USD. Check tangible net worth ratio of Eyepoint Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Eyepoint Pharmaceuticals Inc (2000–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Eyepoint Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.3% | $334.26 Million | $336.50 Million | $383.31 Million | $49.05 Million | ▼ -6.4 pp |
| 2023 | 105.7% | $281.54 Million | $266.32 Million | $344.80 Million | $63.26 Million | ▼ -37.8 pp |
| 2022 | 143.5% | $138.27 Million | $96.37 Million | $172.81 Million | $34.54 Million | ▲ +27.4 pp |
| 2021 | 116.1% | $214.09 Million | $184.38 Million | $237.75 Million | $23.66 Million | ▼ -144.0 pp |
| 2020 | 260.1% | $48.23 Million | $18.54 Million | $63.12 Million | $14.89 Million | ▼ -102.4 pp |
| 2019 | 362.5% | $30.20 Million | $8.33 Million | $41.72 Million | $11.52 Million | ▲ +206.4 pp |
| 2018 | 156.1% | $18.25 Million | $11.69 Million | $39.91 Million | $21.66 Million | ▲ +62.8 pp |
| 2017 | 93.4% | $12.45 Million | $13.34 Million | $17.74 Million | $5.29 Million | ▼ -25.7 pp |
| 2016 | 119.1% | $24.87 Million | $20.88 Million | $29.96 Million | $5.09 Million | ▲ +5.7 pp |
| 2015 | 113.4% | $26.49 Million | $23.37 Million | $29.84 Million | $3.35 Million | ▼ -2.0 pp |
| 2014 | 115.4% | $17.22 Million | $14.92 Million | $19.34 Million | $2.13 Million | ▼ -3.6 pp |
| 2013 | 119.0% | $9.16 Million | $7.70 Million | $12.46 Million | $3.30 Million | ▲ +25.2 pp |
| 2012 | 93.7% | $12.78 Million | $13.64 Million | $15.96 Million | $3.18 Million | ▲ +39.4 pp |
| 2011 | 54.3% | $20.33 Million | $37.43 Million | $25.37 Million | $5.03 Million | ▲ +5.6 pp |
| 2010 | 48.7% | $16.10 Million | $33.04 Million | $19.03 Million | $2.93 Million | ▲ +51.2 pp |
| 2009 | -2.5% | $-592.00K | $23.54 Million | $8.13 Million | $8.72 Million | ▲ +7.6 pp |
| 2008 | -10.1% | $-2.20 Million | $21.79 Million | $10.91 Million | $13.11 Million | ▲ +8.7 pp |
| 2007 | -18.8% | $-12.40 Million | $65.91 Million | $5.69 Million | $18.09 Million | ▲ +8.0 pp |
| 2006 | -26.8% | $-17.72 Million | $66.20 Million | $6.16 Million | $23.89 Million | ▼ -41.6 pp |
| 2005 | 14.8% | $9.02 Million | $60.74 Million | $10.57 Million | $1.56 Million | ▲ +0.0 pp |
| 2004 | 14.8% | $9.02 Million | $60.74 Million | $10.57 Million | $1.56 Million | ▼ -62.7 pp |
| 2003 | 77.5% | $20.70 Million | $26.70 Million | $22.05 Million | $1.35 Million | ▲ +70.6 pp |
| 2002 | 6.9% | $291.30K | $4.23 Million | $879.68K | $588.38K | ▼ -27.8 pp |
| 2000 | 34.7% | $1.59 Million | $4.57 Million | $1.73 Million | $145.74K | — |